Evidence-Based Complementary and Alternative Medicine

Volume 2012 (2012), Article ID 124703, 9 pages

doi:10.1155/2012/124703

Review Article

Effects of Yoga Interventions on Fatigue: A Meta-Analysis

Katja Boehm, Thomas Ostermann, Stefania Milazzo, and Arndt Büssing

Center for Integrative Medicine, Faculty of Medicine, University of Witten/Herdecke, 58239 Herdecke, Germany

Received 5 June 2012; Revised 25 July 2012; Accepted 26 July 2012

Academic Editor: Andreas Michalsen

Copyright © 2012 Katja Boehm et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Background. Researchers aimed at systematically reviewing and meta-analyzing the effectiveness of yoga interventions for fatigue. Methods. PubMed/Medline was searched until January 2012 for controlled clinical studies. Two reviewers independently extracted the data. The methodological quality of the studies was assessed. A meta-analysis was performed. Results. Nineteen clinical studies (total ) were included in this review. Investigated yoga styles included Hatha, Iyengar, Asanas, Patanjali, Sahaja, and Tibetan yoga. Participants were suffering from cancer, multiple sclerosis, dialysis, chronic pancreatitis, fibromyalgia, asthma, or were healthy. Yoga had a small positive effect on fatigue (SMD = 0.27, 59% CI = 0.23–0.31). Seven studies received 4 points on the Jadad score. There were baseline differences in at least 5 studies. Conclusion. Overall, the effects of yoga interventions on fatigue were only small, particularly in cancer patients. Although yoga is generally a safe therapeutic intervention and effective to attenuate other health-related symptoms, this meta-analysis was not able to define the powerful effect of yoga on patients suffering from fatigue. Treatment effects of yoga could be improved in well-designed future studies. According to the GRADE recommendations assessing the overall quality of evidence, there is a moderate effect of the confidence placed in the estimates of the effects discussed here.

1. Introduction

Prolonged fatigue is defined as self-reported, persistent fatigue lasting 1 month or longer. In the United States it is reported that 24% of the general adult population has had fatigue lasting 2 weeks or longer; 59% to 64% of these persons reported that their fatigue has no defined medical cause [1, 2]. When fatigue cannot be specifically explained by a medical condition such as anemia or hypothyroidism, it may represent a chronic fatigue syndrome. Chronic fatigue syndrome is an illness characterized by profound disabling fatigue lasting at least 6 months (persistent or relapsing) and accompanied by numerous rheumatological, infectious, and/or neuropsychiatric symptoms [3]. The presence of chronic fatigue requires clinical evaluation to identify any conditions underlying or contributing which may require treatment. Further diagnosis cannot be made without such an evaluation.

Risk factors for fatigue are cancer and its treatment, pain, nausea, depressive symptoms, and other psychological dysfunctions or burdens. All models that try to explain the cause and development of fatigue assume that there are complex, multicausal processes that create the disability. Suggested pathophysiological factors include a dysregulation of inflammatory cytokines, interruption of the regulatory circuits of the hypothalamus, changes in the serotonin system of the central nervous system, and interruption of the circadian secretion of melatonin and of the circadian rhythm [4–15].

Among the various treatment strategies, that is, exercise, psychosocial support, stress management, nutrition, sleep regulation, and restorative therapy [34], physical activity was identified as important particularly for patients with advanced stages of cancer to attenuate anxiety, depression, stress, and fatigue [35]. Also, meditation programs were shown to improve mood and sleep quality and to reduce stress and fatigue in cancer patients [36]. Yoga, one of the best known and frequently used mind-body interventions, combines physical exercises and meditation [37] and might thus also be effective to attenuate fatigue.

Yoga’s conceptual background originates in Indian philosophy, and there are numerous schools or types of yoga (i.e., Iyengar, Viniyoga, Sivananda, etc.) with distinct priorities in terms of spiritual and physical practices [37]. A typical yoga session with a specific sequence of postures (asanas of Hatha Yoga), breathing techniques (pranayama), and mental concentration/meditation (dhyana) lasts between 1 and 2 hours.

Presumed benefits of yoga include increased muscular strength, flexibility, range of motion, energy, relaxation, and sense of well-being, decreased pain, improved sleep quality, stress reduction, and control over physiological parameters [26, 38–41].

So far, in one RCT it has been demonstrated that the practice of yoga improves fatigue levels in psychiatric inpatients following at least one yoga session [42]. Furthermore, it was shown in a 4-month RCT that yoga could reduce fatigue scores in asthma patients [25] and a 12-week intervention with an RCT design also reduced fatigue scores in patients with chronic pancreatitis [43]. This range of health conditions shows that yoga is being used as a therapy for patients with numerous conditions, some of which involve fatigue.

Thus, yoga could in fact be a beneficial supportive intervention to attenuate fatigue, but there is currently lack of an adequate meta-analysis to assess its effectiveness with respect to fatigue symptoms. To assess its putative relevance in the treatment of patients with fatigue caused by various conditions, we performed a meta-analysis of the current literature focusing on fatigue and fatigue-associated disability.

2. Materials and Methods

2.1. Literature Search Strategy

We searched the electronic literature database PubMed/Medline until January 2012 for clinical studies focusing on yoga interventions and fatigue. English language search terms were “yoga * fatigue.” To increase the chance to find all relevant publications describing the effects of yoga interventions on fatigue, there were no limitations in the initial search in terms of language, year, status, or design. Reference lists of reviews on yoga for fatigue were scanned for further trials. Finally, experts were contacted for gray literature not listed in the databases mentioned above, and reference lists of relevant articles and authors were checked.

2.2. Selection Criteria

All potentially eligible studies were retrieved and the full-text articles were reviewed to determine whether they met the inclusion criteria.

Inclusion criteria were controlled clinical studies (randomized or nonrandomized) addressing the effects of yoga interventions on fatigue symptoms. The findings were analyzed with respect to fatigue scores on various outcome measures. We excluded case series, case reports, studies lacking a control group, expert statements, and theoretical reflections. We also excluded studies with complex interventions such as mindful-based stress reduction (MBSR) programs (which include yoga practices), because the contributing effects of the relevant elements cannot be distinguished.

2.3. Data Extraction

Review authors (S. M. and A. B.) assessed studies for inclusion in the review. They took part in the extraction of data and independent assessment of methodological quality (S. M. and K. B.). Disagreements were resolved by consensus. We extracted study data on the following topics: general study design (prospective, multicenter, etc.), treatment allocation (randomization, matched pairs, etc.), treatment concealment and blinding, treatments (yoga style and practices, duration and frequency, type of control intervention), patient characteristics (mean age, gender distribution), diagnosis, adherence to therapy (compliance, drop-outs, etc.), and outcome assessments, that is, fatigue scores pre-post.

To assess the methodological quality of the respective studies, we adopted the Jadad score which refers to randomization (0 to 2 points), blinding of the assessor (statistician, physician, assessor, or researcher, as cited in the original publications; 0 to 1 points), and dropout reporting (0 or 1 point) as indicators of methodological quality of a study [44]. Because it is impossible to blind also patients (double blind) in yoga studies, the maximum achievable Jadad score was 4 in our review. However, while it is clear what blinding of a “statistician” means, it is not very clear what blinding of “researcher” (as it was stated in some studies) may mean; we assumed that this term refers to the outcome assessor.

Allocation concealment was assessed in accordance with the Cochrane guidelines [45]: A means adequate (telephone randomization or using consecutively numbered, sealed, opaque envelopes); B means uncertainty about the concealment (method of concealment is not known); C means inadequate (e.g., alternate days, odd/even date of birth, hospital number).

2.4. Statistical Analysis

All relevant outcome data were extracted as they were given in the publication. They were converted into standardized mean differences (SMD) and their standard errors (SE) using standard formulas [45]. An SMD 0.2 indicates a small effect, 0.5 a moderate, and 0.8 a large effect [46].

Overall estimates of the treatment effect were obtained from random effects meta-analysis [47]. We performed various subgroup analyses with respect to condition, methodological quality, and duration of treatment. Heterogeneity between studies was assessed by standard χ²-tests and the I² coefficient which measures the percentage of total variation across studies due to true heterogeneity rather than chance [48]. I² coefficients 25% would indicate low, 30–60% moderate, and >75% high heterogeneity.

Heterogeneity was formed by study quality (high: Jadad score = 4 and allocation concealment = A), moderate quality (scores 2-3), low quality (score 0-1), and type of control group (waiting list: routine care only; active treatment: any other intervention given additionally to routine care). Funnel plot asymmetry was assessed by Egger’s test [31].

Finally, we carried out a grading of recommendations assessment, development, and evaluation (GRADE) in order to being able make judgments about evidence and recommendations in this field of yoga for fatigue. The GRADE system judges and rates the quality of the evidence underlying the recommendation made in a meta-analysis [50]. During this process factors that affect the strength of a recommendation include the quality of evidence, the uncertainty about the balance between beneficial and harmful consequences, the uncertainty or variability in values and preferences, and the uncertainty about whether the intervention represents a wise use of resources [51]. The quality assessment includes factors such as the design of the study, rating the level of quality and its limitations, rating the consistency across included studies, and the directedness of outcome measures [52].

3. Results

3.1. Literature Search Results

We found 23 potentially relevant studies addressing the effects of yoga on fatigue [16–23, 27–30, 32, 33, 49, 53–59]. Among them, four studies were excluded because either they delivered no baseline data, had no control group, or measured but did not report pre-post fatigue scores. Nineteen controlled studies with a total of 948 patients were considered eligible for inclusion (Figure 1).

Figure 1: Flow chart.

3.2. Participant Characteristics

The type of patients included breast cancer patients ( studies), different types of cancer (), lymphoma (), patients with multiple sclerosis (), dialysis (), chronic pancreatitis (), fibromyalgia (), asthma (), and also healthy participants (). The number of individuals analyzed varied considerably from 14 to 135 (mean ± SD: ) (Table 1).

Table 1: Overview of identified studies.

First Author [Study-ID]
Year
Fatigue condition
(analyzed)
Yoga style
Control intervention(s)
Duration of treatment
Methodological quality*
Instrument
SMD
SD

Bower et al. [4]
2011
Breast cancer
31
Iyengar
Health education class
12 weeks
4
FSI
0.95
0.14

Carson et al. [16]
2009
Breast cancer
30
Yoga awareness
Waiting list
8 weeks
4
Diary
0.93
0.09

Chandwani et al. [17]
2010
Breast cancer
61
Patanjali
Waiting list
6 weeks
3
BFI
0.66
0.07

Littman et al. [18]
2011
Breast cancer
63
Hatha
Waiting list
24 weeks
3
FACT-F
−0.01
0.06

Vadiraja et al. [19]
2009
Breast cancer
75
Asanas, Pranayama
Supportive counseling
6 weeks
3
EORTC
0.74
0.24

Banasik et al. [20]
2011
Breast cancer
14
Iyengar
Waiting list
8 weeks
2
Cella’s FACT-B
1.62
0.24

Danhauer et al. [21]
2009
Breast cancer
27
Asanas, Pranayama
Waiting list
10 weeks
2
FACT-F
0.51
0.14

Moadel et al. [22]
2007
Breast cancer
128
Hatha
Waiting list
12 weeks
2
FACT-F
0.05
0.03

Carson et al. [23]
2010
Fibromyalgia
50
Yoga awareness
Waiting list
8 weeks
4
FIQ-R
0.26
0.08

Cohen [24]
2004
Lymphoma
39
Tibetan
Waiting list
7 weeks
4
BFI
0.00
0.10

Manocha et al. [25]
2002
Asthma
59
Sahaja
Relaxation, group discussion, CBT
16 weeks
4
POMS

Oken et al. [26]
2004
Multiple sclerosis
57
Iyengar
Waiting list/Exercise class + stationary bike
24 weeks
4
MFI
0.63
0.31

Oken et al. [27]
2006
Healthy
135
Hatha
Waiting list/Exercise class + walking
24 weeks
4
MFI
0.03
0.21

Speca et al. [28]
2000
Different types of cancer
90
Yoga stretches
Waiting list
7 weeks
3
POMS
0.38
0.21

Yurtkuran et al. [29]
2007
Dialysis
40
Asanas
Standard therapy
12 weeks
3
VAS
0.01
0.07

Khalsa et al. [30]
2011
Healthy
121
Yoga education class
Physical education class
11 weeks
2
POMS
0.48
0.11

Sareen et al. [31]
2007
Chronic pancreatitis
52
Iyengar
Standard therapy
12 weeks
2
SF-36
1.36
0.30

Berger et al. [32]
1992
Healthy
50
Hatha
Swimming
14 weeks
1
POMS
0.93
0.09

Velikonja et al. [33]
2010
Multiple sclerosis
nr
Hatha
Sports climbing
10 weeks
1
MFI
0.29
0.14

*Jadad score.

3.3. Study Designs and Methodological Quality

According to specifications in the articles, all 19 studies had a prospective design. Eighteen studies were randomized, whereas one study was not randomized. Seven studies were single blinded (i.e., statistician, physician, assessor, or researcher, as stated in the respective studies) and randomized and thus had a higher methodological quality (JADAD score 4). Ten studies were randomized (without blinding) and displayed a moderate methodological quality (scores 2-3). One study was randomized but with a low quality (Jadad score 1) (Table 1).

Eleven studies applied a waiting-list control group design of which 2 others also had a third active control group either attending an exercise class using a stationary bike or a walking exercise class. Two further studies applied a design where one control group received standard care and one of these 2 trials also had an active control group which received supportive counseling. Other active controls were a health education and a physical education class, sports climbing, swimming, relaxation, and cognitive behavioral therapy.

The methodological quality of the studies ranged from very low to medium. Two clinical trials only received one point on the Jadad score, five studies received 2 points, 5 studies received 3 points, and 7 further studies received the maximum of 4 points. Ten studies were assuring blinding of the outcome assessor, which means that in the interpretation of the remaining studies a detection bias should be taken into account. Only 7 studies addressed incomplete outcome data, meaning that rest of the trials is under the influence of attrition bias. Twelve studies analyzed their data based on intention to treat. Apart from 2 trials all others described the dropout rate and how the data were dealt with.

3.4. Intervention Characteristics: Duration of Intervention

Researchers in those included studies applied Hatha, Iyengar, Asanas, Patanjali, Sahaja, and Tibetan yoga. The whole duration of taught yoga classes lasted between 5 and 24 weeks with the majority of studies lasting more than 8 weeks.

3.5. Outcome Measures

Most of these studies measured more symptom outcomes than merely fatigue, for instance, anxiety, depression, and sleep disturbance. Instruments to measure fatigue symptoms were MFI, POMS, SF-36, FACT-F, EORTC, BFI, diaries, and visual analogue scales (VAS).

3.6. Effect Sizes Fatigue

As shown in Table 1, most studies reported positive effects in favor of the yoga interventions. With respect to fatigue, a random effect meta-analysis estimated the overall treatment effect at SMD = 0.27 [0.23; 0.31] ranging from − to (Figure 2). Overall heterogeneity of study results was high (.

Figure 2: Forest plot with effect sizes for included studies, SMD = 0.27 [0.23–0.31], .

3.7. Subgroup Analyses

Subgroup analysis (Table 2) enrolling only those studies with comparable means at baseline showed effect sizes ranging from − to . Those studies with a high methodological quality showed less of an effect of the yoga intervention on fatigue (SMD = 0.24 [0.18; 0.29]) than those with high quality (SMD = 0.46 [0.37; 0.55]).

Table 2: Subgroup analyses.

Subgroup
Enrolled studies (ID numbers)
SMD
95% CI

Overall
1, 2, 4, 5, 7, 11, 12, 14, 16, 17, 19, 21, 24, 25, 28, 29, 31, 32, 33
0.27
0.23–0.31
94.4%

Jadad score

    High
4, 5, 16, 17, 25, 29, 32
0.46
0.37; 0.55
93.3%

    Intermediate
7, 12, 19, 24, 28
0.23
0.15; 0.30
94.3%

    Low
1, 2, 11, 14, 21, 31, 33
0.24
0.18; 0.29
96.0%

Control group*

    Waiting list
1, 4, 5, 7, 12, 14, 25, 28, 31
0.22
0.18; 0.27
95.8%

    Other controls
2, 11, 19, 21, 24, 29, 32, 33
0.47
0.38; 0.55
93.7%

Condition

    Cancer
1, 4, 7, 12, 14, 19, 25, 28, 29, 31
0.20
0.15; 0.24
94.3%

    Noncancer
2, 5, 11, 16, 17, 21, 24, 32, 33
0.46
0.24; 0.67
76.6%

*Excluded from analysis since more than 1 control (Oken et al. [27], Oken et al. [49]).

Trials with a waiting list control group also showed less of an effect (SMD = 0.22 [0.18; 0.27]) than those that used other controls such as, for instance, health education class, relaxation, swimming, or exercise (SMD = 0.47 [0.38–0.55]) (Table 2).

Interestingly, studies enrolling (breast) cancer patients had lower effects in favor of yoga than those studies with other conditions (including healthy individuals) (Tables 1 and 2).

3.8. Nonrandomized Study

One study was included that was non-randomised. Velikonja et al. [33] carried out a clinical controlled trial with 50 healthy participants who chose either to take part in a Hatha yoga class or to attend a swimming class for a 14-day treatment period. Changes in fatigue were assessed with the POMS and there was a positive effect of the yoga over the swimming (SMD = 0.93 (SD = 0.09)).

4. Discussion

The findings of this meta-analysis, enrolling 18 RCT, with single-blinding and 1 N-RCT, indicate small effects of yoga interventions on fatigue, particularly in patients with cancer.

The overall treatment effects were weak, while the heterogeneity was high. Subgroup analyses did not provide further explanations (i.e., studies with passive control had smaller effects that those with an active control; studies with higher quality had better effects than those with low quality). In fact, among 7 studies with a high quality (Jadad score 4), 4 studies had high treatment effects, 1 study a weak effect, and 2 studies no effect. The highest effects were observed in studies with low quality (Jadad score 1-2), but the lowest, too. This may be attributed to the fact that generally adequate sample sizes in the high-quality studies permitted a greater statistical power to detect any beneficial effects of the treatments. Possibly, further sub-group analyses could provide an indication of confounding variables which were not taken into consideration in this meta-analysis.

It was striking that studies enrolling patients with cancer had lower effects than those with other conditions. One may conclude that the effectiveness of yoga interventions to attenuate cancer-related fatigue is limited. Nevertheless, at least four of these studies had strong effects in favor of the yoga interventions, while two studies (and one study enrolling lymphoma patients) showed no beneficial effects compared to the control group. Most of these studies had a passive control, and thus one may expect effects in favor of the yoga group. Moreover, among these studies one may find those with both higher and lower quality, different types of yoga styles, and differences in the duration of treatments (7 to 24 weeks)—and thus one cannot easily attribute the effects to differences in quality of the studies. Because of these less clear-cut data with respect to cancer-related fatigue, more convincing high-quality studies with active controls and circumscribed duration of treatment (i.e., 12 weeks) are highly encouraged to draw valid conclusions.

With respect to other indications, yoga had weak effects on fatigue in patients with fibromyalgia (SMD 0.26), while in two studies with multiple sclerosis the effects ranged from SMD 0.29 to 0.63. The effects were much better in a study with weak methodology enrolling patients with chronic pancreatitis (SMD 1.36). There were no relevant effects in patients with dialysis and lymphoma. However, three studies addressed fatigue symptoms in healthy individuals; two studies with weak methodology reported positive effects (SMD ranging from 0.48 to 0.93), while one study with higher quality showed no effect in favor of yoga (SMD 0.03). Thus, the evidence that yoga might be effective to treat fatigue symptoms in noncancer diseases is so far rather weak. Although the summarized treatment effects in the cancer studies were weak, there are at least some promising studies which indicate that the treatment effects could be improved. It was of interest that the best results in cancer patients were yielded in those studies with shorter duration of treatment which could indicate that motivation of cancer patients might be a crucial factor too.

Certainly, this meta-analysis has its limitations. For example, the pooled estimates were based on heterogeneous data, with respect to indications, control groups, duration of treatment, yoga style, and methodological quality of these studies. The time intervals of measuring pre/post-fatigue were different across all studies. Furthermore, one non-randomized study was included in the meta-analysis (Velikonja et al., [33])—albeit discussed separately. A general problem in this field of research also seems to be the variety of outcome measures used for the given endpoint—in this case fatigue symptoms. For instance, the “vitality” subscale on the SF-36 does not adequately capture fatigue since the used items do not capture the full burden of chronic fatigue, which is reflected by the developing research team who defines minimum vitality as “feeling tired and not as fatigued.” With respect to the GRADE criteria (Table 3), there were neither serious risks of bias nor serious inconsistency, indirectness, nor imprecision. Overall, the estimated treatment effect of the papers was moderate, but the studies’ outcome effects were not associated with their methodological quality.

Table 3: GRADE recommendation: Fatigue (assessed with: various fatigue subscales).

Quality assessment
No of patients (yoga: control)
Effect SMD (95% CI)
Quality

No. of studies
Design
Risk of bias
Inconsistency
Indirectness
Imprecision
Other considerations

19
RCT
No serious risk of bias
Serious¹
No serious indirectness
No serious imprecision
None
458 : 490
SMD = 0.27, 95% CI = 0.23–0.31, = 94.4%
Moderate

1Baseline differences between groups in at least 5 studies.

Future studies should also address patients’ motivation, impacts not only the number of drop-outs, but also the (intrinsic) intensity of practice (“inner congruence”). These studies have to identify which patients may benefit from the interventions [60] and which aspects of the yoga interventions (i.e., physical activity and/or meditation and subsequent life style modification) or which specific yoga styles were more effective than others.

5. Conclusion

Although yoga is in general a safe therapeutic intervention and effective to attenuate several other health-related symptoms, this meta-analysis is not able to define relevant effects of yoga on patients suffering from fatigue. According to the GRADE recommendations assessing the overall quality of evidence, there is a moderate confidence effect of the confidence placed in the estimates of the effects discussed here (Table 3). Nevertheless, there are some studies on cancer-related fatigue which indicate that treatment effects of yoga could be improved in well-designed future studies.

Acknowledgment

The authors would like to thank Professor G. B. Marks for the supply of some missing values.

References

R. K. Price, C. S. North, S. Wessely, and V. J. Fraser, “Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community,” Public Health Reports, vol. 107, no. 5, pp. 514–522, 1992.

E. A. Walker, W. J. Katon, and R. P. Jemelka, “Psychiatric disorders and medical care utilization among people in the general population who report fatigue,” Journal of General Internal Medicine, vol. 8, no. 8, pp. 436–440, 1993.

K. Fukuda, S. E. Straus, I. Hickie, M. C. Sharpe, J. G. Dobbins, and A. Komaroff, “The chronic fatigue syndrome: a comprehensive approach to its definition and study,” Annals of Internal Medicine, vol. 121, no. 12, pp. 953–959, 1994.

J. E. Bower, P. A. Ganz, M. R. Irwin, L. Kwan, E. C. Breen, and S. W. Cole, “Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?” Journal of Clinical Oncology, vol. 29, no. 26, pp. 3517–3522, 2011.

J. E. Bower, P. A. Ganz, N. Aziz, R. Olmstead, M. R. Irwin, and S. W. Cole, “Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids,” Brain, Behavior, and Immunity, vol. 21, no. 3, pp. 251–258, 2007.

C. Schubert, S. Hong, L. Natarajan, P. J. Mills, and J. E. Dimsdale, “The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review,” Brain, Behavior, and Immunity, vol. 21, no. 4, pp. 413–427, 2007.

A. Jager, S. Sleijfer, and C. C. D. van der Rijt, “The pathogenesis of cancer related fatigue: could increased activity of pro-inflammatory cytokines be the common denominator?” European Journal of Cancer, vol. 44, no. 2, pp. 175–181, 2008.

J. Kamath, G. G. Yarbrough, A. J. Prange, and A. Winokur, “The thyrotropin-releasing hormone (TRH)-immune system homeostatic hypothesis,” Pharmacology and Therapeutics, vol. 121, no. 1, pp. 20–28, 2009.

J. Kamath, G. G. Yarbrough, A. J. Prange, and A. Winokur, “Thyrotropin-releasing hormone can relieve cancer-related fatigue: hypothesis and preliminary observations,” Journal of International Medical Research, vol. 37, no. 4, pp. 1152–1157, 2009.

F. Strasser, J. L. Palmer, L. R. Schover et al., “The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study,” Cancer, vol. 107, no. 12, pp. 2949–2957, 2006.

J. E. Bower, “Cancer-related fatigue: links with inflammation in cancer patients and survivors,” Brain, Behavior, and Immunity, vol. 21, no. 7, pp. 863–871, 2007.

S. Alexander, P. Stone, S. White, P. Andrews, S. Nussey, and G. Bano, “Evaluation of central serotonin sensitivity in breast cancer survivors with cancer-related fatigue syndrome,” Journal of Pain and Symptom Management, vol. 40, no. 6, pp. 892–898, 2010.

J. K. Payne, “Altered circadian rhythms and cancer-related fatigue outcomes,” Integrative Cancer Therapies, vol. 10, no. 3, pp. 221–233, 2011.

A. M. Berger, K. Wielgus, M. Hertzog, P. Fischer, and L. Farr, “Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy,” Supportive Care in Cancer, vol. 18, no. 1, pp. 105–114, 2010.

T. A. Rich, “Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis,” Journal of Supportive Oncology, vol. 5, no. 4, pp. 167–174, 2007.

J. W. Carson, K. M. Carson, L. S. Porter, F. J. Keefe, and V. L. Seewaldt, “Yoga of Awareness program for menopausal symptoms in breast cancer survivors: results from a randomized trial,” Supportive Care in Cancer, vol. 17, no. 10, pp. 1301–1309, 2009.

K. D. Chandwani, B. Thornton, G. H. Perkins et al., “Yoga improves quality of life and benefit finding in women undergoing radiotherapy for breast cancer,” Journal of the Society for Integrative Oncology, vol. 8, no. 2, pp. 43–55, 2010.

A. J. Littman, L. C. Bertram, R. Ceballos et al., “Randomized controlled pilot trial of yoga in overweight and obese breast cancer survivors: effects on quality of life and anthropometric measures,” Supportive Care in Cancer, vol. 20, no. 2, pp. 267–277, 2011.

S. H. Vadiraja, M. R. Rao, R. H. Nagendra et al., “Effects of yoga on symptom management in breast cancer patients: a randomized controlled trial,” International Journal of Yoga, vol. 2, no. 2, pp. 73–79, 2009.

J. Banasik, H. Williams, M. Haberman, S. E. Blank, and R. Bendel, “Effect of Iyengar yoga practice on fatigue and diurnal salivary cortisol concentration in breast cancer survivors,” Journal of the American Academy of Nurse Practitioners, vol. 23, no. 3, pp. 135–142, 2011.

S. C. Danhauer, S. L. Mihalko, G. B. Russell et al., “Restorative yoga for women with breast cancer: finding from a randomized pilot study,” Psycho-Oncology, vol. 18, no. 4, pp. 360–368, 2009.

A. B. Moadel, C. Shah, J. Wylie-Rosett et al., “Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life,” Journal of Clinical Oncology, vol. 25, no. 28, pp. 4387–4395, 2007.

J. W. Carson, K. M. Carson, K. D. Jones, R. M. Bennett, C. L. Wright, and S. D. Mist, “A pilot randomized controlled trial of the Yoga of awareness program in the management of fibromyalgia,” Pain, vol. 151, no. 2, pp. 530–539, 2010.

L. Cohen, C. Warneke, R. T. Fouladi, M. A. Rodriguez, and A. Chaoul-Reich, “Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma,” Cancer, vol. 100, no. 10, pp. 2253–2260, 2004.

R. Manocha, G. B. Marks, P. Kenchington, D. Peters, and C. M. Salome, “Sahaja yoga in the management of moderate to severe asthma: a randomised controlled trial,” Thorax, vol. 57, no. 2, pp. 110–115, 2002.

B. S. Oken, S. Kishiyama, D. Zajdel et al., “Randomized controlled trial of yoga and exercise in multiple sclerosis,” Neurology, vol. 62, no. 11, pp. 2058–2064, 2004.

B. S. Oken, D. Zajdel, S. Kishiyama et al., “Randomized, controlled, six-month trial of yoga in healthy seniors: effects on cognition and quality of life,” Alternative Therapies in Health and Medicine, vol. 12, no. 1, pp. 40–47, 2006.

M. Speca, L. E. Carlson, E. Goodey, and M. Angen, “A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients,” Psychosomatic Medicine, vol. 62, no. 5, pp. 613–622, 2000.

M. Yurtkuran, A. Alp, M. Yurtkuran, and K. Dilek, “A modified yoga-based exercise program in hemodialysis patients: a randomized controlled study,” Complementary Therapies in Medicine, vol. 15, no. 3, pp. 164–171, 2007.

S. B. S. Khalsa, L. Hickey-Schultz, D. Cohen, N. Steiner, and S. Cope, “Evaluation of the mental health benefits of yoga in a secondary school: a preliminary randomized controlled trial,” Journal of Behavioral Health Services and Research, vol. 39, no. 1, pp. 80–90, 2011.

M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” British Medical Journal, vol. 315, no. 7109, pp. 629–634, 1997.

B. G. Berger and D. R. Owen, “Mood alteration with yoga and swimming: aerobic exercise may not be necessary,” Perceptual and Motor Skills, vol. 75, no. 3, pp. 1331–1343, 1992.

O. Velikonja, K. Čurić, A. Ožura, and S. Š. Jazbec, “Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis,” Clinical Neurology and Neurosurgery, vol. 112, no. 7, pp. 597–601, 2010.

K. M. Mustian, G. R. Morrow, J. K. Carroll, C. D. Flgueroa-Moseley, P. Jean-Pierre, and G. C. Williams, “Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue,” Oncologist, vol. 12, no. 1, supplement 1, pp. 52–67, 2007.

T. A. Albrecht and A. G. Taylor, “Physical activity in patients with advanced-stage cancer: a systematic review of the literature,” Clinical Journal of Oncology Nursing, vol. 16, no. 3, pp. 293–300, 2012.

K. A. Biegler, M. Alejandro Chaoul, and L. Cohen, “Cancer, cognitive impairment, and meditation,” Acta Oncologica, vol. 48, no. 1, pp. 18–26, 2009.

G. Feuerstein, The Yoga Tradition: Its History, Literature, Philosophy and Practice, Hohm Press, 1998.

J. A. Raub, “Psychophysiologic effects of Hatha Yoga on musculoskeletal and cardiopulmonary function: a literature review,” Journal of Alternative and Complementary Medicine, vol. 8, no. 6, pp. 797–812, 2002.

M. D. Tran, R. G. Holly, J. Lashbrook, and E. A. Amsterdam, “Effects of hatha yoga practice on the health-related aspects of physical fitness,” Preventive Cardiology, vol. 4, no. 4, pp. 165–170, 2001.

R. P. Vempati and S. Telles, “Yoga-based guided relaxation reduces sympathetic activity judged from baseline levels,” Psychological Reports, vol. 90, no. 2, pp. 487–494, 2002.

A. Malathi, A. Damodaran, N. Shah, N. Patil, and S. Maratha, “Effect of yogic practices on subjective well-being,” Indian Journal of Physiology and Pharmacology, vol. 44, no. 2, pp. 202–206, 2000.

R. Lavey, T. Sherman, K. T. Mueser, D. D. Osborne, M. Currier, and R. Wolfe, “The effects of yoga on mood in psychiatric inpatients,” Psychiatric Rehabilitation Journal, vol. 28, no. 4, pp. 399–402, 2005.

S. Sareen, V. Kumari, K. S. Gajebasia, and N. K. Gajebasia, “Yoga: a tool for improving the quality of life in chronic pancreatitis,” World Journal of Gastroenterology, vol. 13, no. 3, pp. 391–397, 2007.

A. R. Jadad, R. A. Moore, D. Carroll et al., “Assessing the quality of reports of randomized clinical trials: is blinding necessary?” Controlled Clinical Trials, vol. 17, no. 1, pp. 1–12, 1996.

J. P. T. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions, Version 5. 0. 1, The Cochrane Collaboration, 2008.

J. L. Fleiss, “The statistical basis of meta-analysis,” Statistical Methods in Medical Research, vol. 2, no. 2, pp. 121–145, 1993.

J. P. T. Higgins and S. G. Thompson, “Quantifying heterogeneity in a meta-analysis,” Statistics in Medicine, vol. 21, no. 11, pp. 1539–1558, 2002.

F. M. Wolf, Meta-Analysis: Quantitative Methods for Research Synthesis, Sage, Beverly Hills, Calif, USA, 1986.

B. S. Oken, S. Kishiyama, D. Zajdel et al., “Randomized controlled trial of yoga and exercise in multiple sclerosis,” Neurology, vol. 62, no. 11, pp. 2058–2064, 2004.

G. H. Guyatt, A. D. Oxman, G. E. Vist et al., “GRADE: an emerging consensus on rating quality of evidence and strength of recommendations,” BMJ, vol. 336, no. 7650, pp. 924–926, 2008.

R. Kunz, B. Djulbegovic, H. J. Schunemann, M. Stanulla, P. Muti, and G. Guyatt, “misconceptions, challenges, uncertainty, and progress in guideline recommendations,” Seminars in Hematology, vol. 45, no. 3, pp. 167–175, 2008.

D. Atkins, D. Best, P. A. Briss et al., “Grading quality of evidence and strength of recommendations,” BMJ, vol. 328, no. 7454, p. 1490, 2004.

J. E. Bower, D. Garet, B. Sternlieb et al., “Yoga for persistent fatigue in breast cancer survivors,” Cancer, vol. 118, no. 15, pp. 3766–3775, 2012.

R. Manocha, G. B. Marks, P. Kenchington, D. Peters, and C. M. Salome, “Sahaja yoga in the management of moderate to severe asthma: a randomised controlled trial,” Thorax, vol. 57, no. 2, pp. 110–115, 2002.

S. Sareen, V. Kumari, K. S. Gajebasia, and N. K. Gajebasia, “Yoga: a tool for improving the quality of life in chronic pancreatitis,” World Journal of Gastroenterology, vol. 13, no. 3, pp. 391–397, 2007.

S. N. Culos-Reed, L. E. Carlson, L. M. Daroux, and S. Hately-Aldous, “A pilot study of yoga for breast cancer survivors: physical and psychological benefits,” Psycho-Oncology, vol. 15, no. 10, pp. 891–897, 2006.

A. Woolery, H. Myers, B. Sternlieb, and L. Zeltzer, “A yoga intervention for young adults with elevated symptoms of depression,” Alternative Therapies in Health and Medicine, vol. 10, no. 2, pp. 60–63, 2004.

M. L. Galantino, T. M. Bzdewka, J. L. Eissler-Russo et al., “The impact of modified hatha yoga on chronic low back pain: q pilot study,” Alternative Therapies in Health and Medicine, vol. 10, no. 2, pp. 56–59, 2004.

S. C. Danhauer, J. A. Tooze, D. F. Farmer et al., “Restorative yoga for women with ovarian or breast cancer: findings from a pilot study,” Journal of the Society for Integrative Oncology, vol. 6, no. 2, pp. 47–58, 2008.

A. Büssing, F. Edelhäuser, A. Weisskircher, J. M. Fouladbakhsh, and P. Heusser, “Inner correspondence and peacefulness with practices among participants in eurythmy therapy and yoga: a validation study,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 329023, 9 pages, 2011.